A rare but increasingly more common disease striking overweight, younger women is the focus of a clinical trial at Michigan State University, where an osteopathic physician is testing the effectiveness of a certain drug against a potentially blindness-…
Category: News
Researchers Find That Inhibiting MicroRNAs May Help Prevent Degenerative Eye Disorders
DALLAS – June 7, 2011 – Blocking two tiny molecules of RNA – a chemical cousin of DNA – appears to suppress the abnormal growth of blood vessels that occurs in degenerative eye disorders, UT Southwestern Medical Center researchers have found.
‘A Sticky Situation’ – Part I
Featured Article
Johns Hopkins Study Demonstrates 16% Increase In Patient Adherence Using MEMOTEXT And Microsoft HealthVault In The First Randomized Clinical Trial Of Its Kind In North America.
MEMOTEXT presented “The Impact of Automated Dosing Reminders on Medication Adherence Using HealthVault,” conducted by Johns Hopkins University and funded by the Microsoft HealthVault Be Well Fund at Mobile Health 2011: What Really Works conference at S…
20-20 Vision Perfection Based At The Manchester Face And Eye Clinic First To Offer Innovative Keratoconus Treatment In The United Kingdom
20-20 Vision Perfection announces that it has acquired advanced technology for performing Keraflex™ and KXL™, two new, non-invasive, non-surgical procedures used in combination to treat keratoconus. Mr…
CE Gives Green Light To Dexamethasone For The Treatment Of Common Eye Condition In Draft Guidance
In final draft guidance published today NICE has recommended dexamethasone (Ozurdex, Allergan) intravitreal implant, for the treatment of macular oedema following central retinal vein occlusion (CRVO)i…
Early Light Refines The Brain’s Circuitry For Vision
Creatures are not born hardwired to see. Instead, they depend on electrical activity in the retina to refine the complex circuits that process visual information. Two new studies from Brown University in different species using different techniques sho…
Silencing two microRNAs may help treat age-related macular degeneration
Blocking two tiny molecules of RNA – a chemical cousin of DNA – appears to suppress the abnormal growth of blood vessels that occurs in degenerative eye disorders, UT Southwestern Medical Center researchers have found.
Laser Eye Center Of Carolina First To Offer IFS Laser In North Carolina
Laser Eye Center of Carolina (LECC) announced today that it has become the first and only medical facility in North Carolina to offer patients the benefits of the iFS femtosecond laser for corrective vision procedures such as corneal transplants, catar…
Laser Eye Center Of Carolina First To Offer IFS Laser In North Carolina
Laser Eye Center of Carolina (LECC) announced today that it has become the first and only medical facility in North Carolina to offer patients the benefits of the iFS femtosecond laser for corrective vision procedures such as corneal transplants, catar…
CMSC: Retinal Scans Eyed For Tracking MS
A common retinal imaging technology could eventually supplement or even replace MRI for tracking multiple sclerosis severity and progression, researchers suggested here.
Migraine Visual Auras Present in a Variety of Patterns
A new survey reveals that migraines result in a wide variety of aura symptoms. Medscape Medical News
Merge Healthcare, Ophthalmic Imaging Systems enter definitive merger agreement
Merge Healthcare, a leading provider of healthcare enterprise imaging and interoperability solutions, and Ophthalmic Imaging Systems, a leading provider of digital imaging and informatics solutions for ophthalmology and other medical specialties, today…
Positive data from Biogen Idec’s AVONEX clinical trial on multiple sclerosis presented at CMSC 2011
Biogen Idec today announced the findings from a randomized, multicenter, dose-blinded clinical trial that evaluated the effect of AVONEX dose titration, or gradual dose escalation, on flu-like symptoms associated with the therapy.
Helping Children Succeed – EyeMed Vision Care Introduces EyeMed KidsEyes Vision Benefit
EyeMed Vision Care, one of the nation’s leading vision benefits companies and part of Luxottica (NYSE: LUX), a leader in vision care and eyewear, introduces a first-to-market vision benefit that is tailored to meet the unique needs of children 18 years…
Denali, Can-Fite sign agreement to conclude ophthalmology spinoff
Can-Fite BioPharma Ltd, a biotechnology company developing small molecule drugs for the treatment of inflammatory, ophthalmic, and liver diseases, traded on the Tel Aviv Stock Exchange, signed today an agreement to spin off its ophthalmic indications t…
Lucentis(R) (Ranibizumab) Launched In The UK For The Treatment Of Vision Loss Due To Macular Oedema Secondary To Retinal Vein Occlusion (RVO)
Novartis Pharmaceuticals UK Ltd today announced that Lucentis® (ranibizumab) has launched in the UK for the treatment of visual impairment due to macular oedema secondary to Retinal Vein Occlusion (RVO)…
VEGF Trap-Eye Submitted For EU Marketing Authorization For Treatment Of Wet Age-Related Macular Degeneration
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced thatBayer HealthCare has submitted an application for marketing authorization in Europe for VEGF Trap-Eye for the treatment of the neovascular form of age-related macular degeneration…
New Accommodating Implants Expand Options For Presbyopia Correction
Accommodating lenses will become the preferred method of presbyopia correction, according to a speaker here.
A Change in Thinking: Do Not Enlarge the Cataract Wound When Things Go Downhill
Featured Article